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Abstract
Purpose: The 2019 coronavirus disease pandemic has placed an increased importance on physical distancing to minimize the risk of
transmission in radiation oncology departments. The pandemic has also increased the use of hypofractionated treatment schedules where
magnetic resonance-guided online adaptive radiation therapy (ART) can aid in dose escalation. This specialized technique requires increased
staffing in close proximity, and thus the need for novel coverage practices to increase physical distancing while still providing specialty care.
Methods and Materials: A remote-physician ART coverage practice was developed and described using commercially available
software products. Our remote-physician coverage practice provided control to the physician to contour and review of the images and
plans. The time from completion of image registration to the beginning of treatment was recorded for 20 fractions before remote-
physician ART coverage and 14 fractions after implementation of remote-physician ART coverage. Visual quality was calculated using
cross-correlation between the treatment delivery and remote-physician computer screens.
Results: For the 14 fractions after implementation, the average time from image registration to the beginning of treatment was 24.9 
6.1 minutes. In comparison, the 20 fractions analyzed without remote coverage had an average time of 29.2  9.8 minutes. The
correlation between the console and remote-physician screens was R Z .95.
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Conclusions: Our novel remote-physician ART coverage practice is secure, interactive, timely, and of high visual quality. When using
remote physicians for ART, our department was able to increase physical distancing to lower the risk of virus transmission while
providing specialty care to patients in need.
 2020 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The 2019 coronavirus disease (COVID-19) pandemic
has created a global health care system crisis with increased
demands in medical equipment, space, and staffing.1,2 In
addition to the increased demands, COVID-19 is highly
infectious,3,4 placinghealth careworkers at a riskof infection
while caring for patients5,6 in a time when personal protec-
tive equipment is in short supply.7 This underscores the
importance of developing novel approaches to provide care
for patients while minimizing the risk to patients and staff.8
Radiation oncology departments have responded to the
global pandemic through restructuring of staffing,
reducing patient volume, and implementing triage pro-
cesses for COVID-19esuspected and COVID-
19epositive patients to reduce exposure risks for other
patients and staff. Additionally, radiation oncology de-
partments have adopted more hypofractionated treatment
schedules to decrease patient time in the clinic.9-12 Mag-
netic resonance imaging (MRI)eguided radiation therapy
with daily adaptation is an approach that aids in dose
escalation with shorter treatment regimens.13,14 However,
staffing requirements for daily adaptation include a radi-
ation oncologist, medical physicist, and 2 to 3 radiation
therapists in close proximity for extended periods of time
while sharing common equipment. Possible infection or
reallocation of certain specialty team members, such as
radiation oncologists, could limit the use of these spe-
cialty care procedures. To limit this possibility, new
digital care and coverage practices are needed to reduce
in-person interactions and subsequent transmission risks
for adaptive radiation therapy (ART).
With this in mind, a novel digital method to provide
remote-physician ART coverage for image review, con-
touring, and plan review was created and implemented in
our department. Our remote-physician ART coverage
practice was required to be secure, interactive, of high
visual quality, and timely to provide another avenue for
physical distancing among staff and patients. Herein, we
describe the structure and implementation of a remote-
physician ART coverage practice in our radiation
oncology department.
Methods and materials
Before the COVID-19 pandemic, the ART team
included 2 radiation therapists, an advanced practice
radiation therapist (APRT), a medical physicist, and a
radiation oncologist. Department policies, modeled from
national guidelines for stereotactic body radiation therapy
and prior ART workflow publications,15-20 require
physician presence at every fraction for image approval,
contour review, plan approval, gating window approval,
and to direct treatment. Physicist presence is required for
contour review and assignment, plan generation, quality
assurance, motion management, and troubleshooting. Our
department delivers an average of 4 to 6 ART treatments a
day on an MRI-guided linear accelerator (LINAC; MRI-
dian; ViewRay, Oakwood Village, OH).
The ART process is as follows. The patient is posi-
tioned in a room by the therapy team, followed by
volumetric MRI acquisition with registration and couch-
shift performed by the therapists. For first fraction ste-
reotactic body radiation therapy or hypofractionated
treatments, the physician is physically present for regis-
tration approval and returns after adapted plan generation.
The APRT begins contouring while the medical physicist
arrives during this process to verify contour integrity.
Once contouring is complete, the physicist performs any
necessary additional contouring and generates the adap-
tive plan. The, the physician is called back to the machine
to review contours and the plan. Once approved, the
medical physicist and therapists perform pretreatment
quality assurance. Lastly, all members of the ART team
review the pretreatment real-time MRI cine with the
physician and provide the final approval of gating pa-
rameters. Both the physician and physicist are required to
remain readily available during the treatment delivery.
To facilitate remote coverage, a collaboration with the
vendor was required. A separate, local-area network,
ethernet-connected (WiFi-disconnected) computer behind
the institution’s firewall was secured in the department
and access granted to a limited number of physicists and
physicians. At the beginning of each treatment day, a
new, random password generated TeamViewer (Göppin-
gen, Germany) session was created and communicated
with the vendor engineer without knowledge of the
remote computer’s login. The engineer could then gain
access to the remote computer to create a ScreenConnect
(ConnectWise, Tampa, FL) session with the treatment
delivery system (TDS) that only they could create. Once
the TeamViewer connection was used, the vendor engi-
neer could not log back in unless a new password was
created. The physician can then remotely access the
remote computer via a remote desktop connection to view
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and gain control of the TDS user interface (UI) via the
ScreenConnect software. At the end of the treatment day,
the computer’s ethernet connection is physically discon-
nected to avoid any possibility of unauthorized access of
the TDS. The system design is illustrated in Figure 1.
The remote-physician coverage practice has been
performed for 14 patient treatment fractions thus far. The
physician was required to be physically on campus during
the remote coverage practice. For the remote-physician
coverage practice, a text message was sent during patient
setup, providing the physician adequate time to access the
remote computer. Once ready, the physician called the
therapy team via telephone, enabling verbal communi-
cation during the remote process. Since simultaneous
control of the TDS UI is not advised during this process,
the physician would announce when they would gain
control of the TDS UI. At that point, the ART process
was similar to the pre-COVID-19 process where the
physician could control the cursor to review setup, adjust
registration, contour, review dose, and review/adjust
gating parameters just as they would if physically present
at the machine. A physicist was required to be physically
present during all remote steps and perform dose calcu-
lations. If at any time a member of the ART team felt
uncomfortable with the remote coverage practice, the
physician would come to the machine for in-person
adaptation. Any situations requiring in-person adapta-
tion or ART process interruptions due to remote coverage
were captured.
Visual quality similarity was determined by calculating
cross-correlation21 between the TDS and physician’s
computer screens using a MATLAB script (MathWorks,
Natick, MA). To assess timeliness of the remote coverage
practice, treatment times were collected from the time of
completion of image registration to the time that the
treatment delivery commenced. These data were collected
for 14 patients after implementation of the remote-
physician coverage practice and for 20 randomly
selected patients without remote coverage. All statistical
analyses were performed in Microsoft Excel (Microsoft,
Redmond, WA).
Results
With the assistance of the vendor, we successfully
established a secure and remote connection to our
MRIdian system. To gain access to the TDS UI, 3 levels
of passwords were required. Both the institutional
physicist and vendor were required to initiate the
connection, but only the physicist/physician had the
password to the remote computer desktop and only the
vendor had the password to the ScreenConnect
connection to the MRIdian system to provide increased
security.
Our institution successfully provided remote coverage
and control of the ART process on the MRI-linac system
for 14 ART treatments. Of the 14 remote-physician ART
treatments, 5 included remote contouring by the physi-
cian in addition to image, contour, plan, and gating
parameter review for all treatments. In-person physician
coverage was not needed for any of the patients in this
TDS
















Figure 1 Remote physician adaptive radiation therapy coverage software and hardware system.
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investigation. Excessive background noises on the call
could cause slight distractions or interruptions in our
process and were addressed with further communication
as needed.
In assessing visual quality of the remote coverage
practice, the correlation between the TDS and remote
computer screens was RZ .95. An example of the remote
coverage screen is shown in Figure 2. Physicians noted a
subjective minimal delay of the cursor motion compared
with being physically at the TDS. They commented that
once one was accustomed to this delay and realized the
cursor would consistently catch up to all motions and
clicks, they could work as efficiently as if physically at
the console.
Over the 14 remote-physician ART fractions, the
average time from image registration completion to
treatment delivery was 24.9  6.1 minutes (median:
25.0 minutes). For the 5 remote-physician contoured
ART fractions, the average time from registration to
treatment delivery was 25.1  7.5 minutes. The sites
treated using the remote coverage practice included 9
liver, 3 pancreas, and 2 adrenal cases from 6 different
patients. For the 20 patients without remote coverage,
the average time from registration completion to treat-
ment delivery was 29.2  9.8 minutes (median: 23.5
minutes). The sites analyzed for in-person coverage
include 15 pancreas, 4 liver, and 1 lung cases from 10
different patients. A distribution of the adaptive process
times is shown in Figure 3.
Discussion
With proper information technology (IT) infrastructure
and vendor collaboration, we successfully implemented a
novel remote-physician ART coverage practice. There
were no hardware or software limitations that prevented
implementation in other radiation oncology departments
with the MRIdian MR-Linac, and potentially other ven-
dors. This novel remote coverage practice provides flex-
ibility during the COVID-19 pandemic owing to staffing
restrictions from illness or reallocation to other de-
partments for clinical care. The practice is especially
useful if a physician has been exposed to a COVID-19
patient, but is asymptomatic and thus clear to work per
hospital policy. The ability for physicians to contour and
approve plans remotely is a high standard of physical
distancing in these increased risk scenarios. With the
physician working remotely, the potential of spread
within the department is decreased because the physician
has more interactions with a variety of groups, including
patients, in the department.
Leadership and compliance teams’ support/approval to
implement this remote-physician ART coverage practice
Figure 2 Example of remote coverage screen.
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was necessary. A potential hurdle to successful imple-
mentation was the added critical physician planning re-
view and approval steps during online ART treatments,
which increase the amount of high-risk potential failure
modes compared with conventional treatments.17,22 Un-
derstanding the risks presented in these previous publi-
cations while incorporating more verbal communication
during the remote-physician coverage practice contributed
to leadership and compliance support. In addition to real-
time remote decision-making, cyber-security concerns for
direct remote control of the TDS over an Internet network
also posed an obstacle. Collaboration with our IT group
and vendor was paramount to ensure proper security of
the system and limit the chance of unauthorized access to
the TDS. Requiring both the vendor engineer and physi-
cist to have login credentials at separate steps in the
process to initiate remote connection also increased se-
curity and lowered the possibility of an individual
mistakenly gaining access to the TDS.
Remote coverage should not degrade the image quality
of the TDS because physicians need to segment and
evaluate contours remotely. Potential image degradation
could lead to inaccurate contours that could negatively
affect patient care. A high correlation translates into
minimal image quality loss and provides physicians with
similar visual perception to in-person coverage.
A remote-physician coverage practice for ART should
not be significantly more time consuming than the
established process. The average times of the adaptive
processes were within 5 minutes of each other, and the
remote-physician coverage practice was even less time
consuming. The remote coverage practice was imple-
mented after our department instituted policies to decrease
patients on treatment, but whether remote-physician
coverage was faster or if these times are a result of
decreased clinical activity is difficult to determine. Our
physicians typically cover multiple radiopharmaceutical
procedures, consultations, follow-up visits, and on-
treatment visits, in addition to their ART coverage roles.
Also, some adaptive cases are more challenging than
others and require more time in the adaptive process to
achieve an appropriate plan, which would not average out
over 14 fractions. Regardless of the need for more data to
confirm its timeliness compared with our traditional
practice, we eliminated upward of 20 to 30 minutes of
physician time physically at the machine; thus, limiting
in-person social interactions associated with the risk of
COVID-19 transmission.
Of note, permission from hospital compliance and
departmental leadership teams was in context of a global
pandemic with high risk of infection to patients and staff.
In a time where proximity can result in morbidity or
mortality, continuing to provide high-quality and short-
ened treatment schedules for radiation oncology patients
is a secure and efficient practice. Outside of a pandemic
setting, remote-physician coverage within a department
may provide faster responses from physicians who may
be located elsewhere in the radiation oncology depart-
ment. Providing remote coverage technology may also
increase the accessibility and relative ease for physicians
to cover patients’ adaptive treatments throughout the
course of radiation therapy; thus, limiting cross overage.
In a scenario where an institution does not have an APRT,
a dosimetrist, physicist, or other physician located in the
department can assist in contouring and/or other workflow
steps based on established processes. The reliance on IT
support and the vendor can make access to this technol-
ogy more difficult if a certain IT expertise or vendor
support is not readily available during implementation or
treatment setup. Further collaboration is needed with
vendors, especially those without remote capabilities, to
improve and/or use this technique on all adaptive plat-
forms. Even without remote control capabilities, remote
view-only of the treatment delivery is possible with
commercially available products23; thus, facilitating some
form of remote coverage practice on other platforms for
the time being.
Future steps for this work include gathering more data
on the timing of the process as the patient load returns to
normal. In addition, we would like to identify if there are
certain treatment sites that should not be covered with
remote-physician ART. Increased remote coverage expe-
rience will help identify these cases. Our institution will
also perform a formal failure mode and effects analysis to
identify crucial steps and further improve our process. In
addition to providing remote coverage, this technology
provides a platform for collaboration among subspecialists
in our department if they are not available to come to the
treatment machine. However, for simultaneous collabora-
tion among multiple users, view-only access may be the
best approach. Based on initial experience, our department
successfully implemented this novel technology, providing
information on treatment coverage alternatives for other
Figure 3 Distribution of adaptive process times with and
without remote coverage.
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institutions with a MRIdian system as we continue to
manage COVID-19 across the world.
Conclusions
At our institution, we were able to implement remote-
physician treatment coverage alternatives for adaptive
radiation therapy on a MRIdian system during the
COVID-19 pandemic. Our system and remote coverage
practice is similarly secure, interactive, of high visual
quality, and timely compared with our in-person treatment
coverage practice. High quality specialty care is still
achievable during the COVID-19 pandemic with remote
techniques that promote physical distancing to help limit
the spread of COVID-19 among our radiation oncology
team and patients.
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